Arterial Function in Cardio-Metabolic Diseases: From the Microcirculation to the Large Conduits

Progress in Cardiovascular Diseases

Volumn 57, Issue 5, 2015, Pages 489-496

  Chantler, Paul D ^a   Frisbee, Jefferson C ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood flow; Insulin resistance; Metabolic syndrome; Obesity; Vascular disease

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ARGINASE; ENDOTHELIN 1; MATRIX METALLOPROTEINASE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ADAPTATION; ANGIOGENESIS; ARTERIAL FUNCTION; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTERY DISEASE; ARTICLE; BLOOD VESSEL FUNCTION; CAPILLARY DENSITY; CARDIOMETABOLIC DISORDER; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; EXERCISE; HUMAN; INFLAMMATION; METABOLIC DISORDER; METABOLIC SYNDROME X; MICROCIRCULATION; MICROVASCULATURE; NONHUMAN; OXIDATIVE STRESS; VASCULAR REMODELING; VASOCONSTRICTION; VASODILATATION; ANIMAL; ARTERY; BLOOD FLOW; CARDIOVASCULAR DISEASES; COMPLICATION; KINESIOTHERAPY; PATHOPHYSIOLOGY; RISK FACTOR;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; ARTERIES; CARDIOVASCULAR DISEASES; EXERCISE THERAPY; HUMANS; METABOLIC SYNDROME X; MICROCIRCULATION; MICROVESSELS; REGIONAL BLOOD FLOW; RISK FACTORS; VASCULAR REMODELING;

EID: 84924763730     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2014.09.005     Document Type: Article

References (87)

1. Alberti K.G.M.M., Eckel R.H., Grundy S.M., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645.
2. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol 2006, 21:1-6.
3. Fournier S.B., Reger B.L., Donley D.A., et al. Exercise reveals impairments in left ventricular systolic function in patients with metabolic syndrome. Exp Physiol 2014, 99:149-163.
4. Scuteri A., Najjar S.S., Muller D.C., et al. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol 2004, 43:1388-1395.
5. Scuteri A., Najjar S.S., Orru' M., et al. The central arterial burden of the metabolic syndrome is similar in men and women: the SardiNIA Study. Eur Heart J 2010, 31:602-613.
6. Protogerou A.D., Blacher J., Aslangul E., et al. Gender influence on metabolic syndrome's effects on arterial stiffness and pressure wave reflections in treated hypertensive subjects. Atherosclerosis 2007, 193:151-158.
7. Brohall G., Odén A., Fagerberg B. Carotid artery intima-media thickness in patients with type 2 diabetes mellitus and impaired glucose tolerance: a systematic review. Diabet Med 2006, 23:609-616.
8. Henry R.M., Kostense P.J., Dekker J.M., et al. Carotid arterial remodeling: a maladaptive phenomenon in type 2 diabetes but not in impaired glucose metabolism: the Hoorn study. Stroke 2004, 35:671-676.
9. Ferreira I., Beijers H.J., Schouten F., Smulders Y.M., Twisk J.W., Stehouwer C.D. Clustering of metabolic syndrome traits is associated with maladaptive carotid remodeling and stiffening: a 6-year longitudinal study. Hypertension 2012, 60:542-549.
10. Glagov S., Vito R., Giddens D.P., Zarins C.K. Micro-architecture and composition of artery walls: relationship to location, diameter and the distribution of mechanical stress. J Hypertens 1992, 10:S101-S104.
11. Marchesi C., Ebrahimian T., Angulo O., Paradis P., Schiffrin E.L. Endothelial nitric oxide synthase uncoupling and perivascular adipose oxidative stress and inflammation contribute to vascular dysfunction in a rodent model of metabolic syndrome. Hypertension 2009, 54:1384-1392.
12. Safar M.E., Thomas F., Blacher J., et al. Metabolic syndrome and age-related progression of aortic stiffness. J Am Coll Cardiol 2006, 47:72-75.
13. Scuteri A., Cunha P.G., Agabiti Rosei E., et al. Arterial stiffness and influences of the metabolic syndrome: a cross-countries study. Atherosclerosis 2014, 233:654-660.
14. Tedesco M.A., Natale F., Di Salvo G., Caputo S., Capasso M., Calabro R. Effects of coexisting hypertension and type II diabetes mellitus on arterial stiffness. J Hum Hypertens 2004, 18:469-473.
15. Weisbrod R.M., Shiang T., Al Sayah L., et al. Arterial stiffening precedes systolic hypertension in diet-induced obesity. Hypertension 2013, 62:1105-1110.
16. Kangas P., Tikkakoski A.J., Tahvanainen A.M., et al. Metabolic syndrome may be associated with increased arterial stiffness even in the absence of hypertension: a study in 84 cases and 82 controls. Metabolism 2013, 62:1114-1122.
17. Lorenz M.W., Markus H.S., Bots M.L., Rosvall M., Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness. Circulation 2007, 115:459-467.
18. Vlachopoulos C., Aznaouridis K., Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010, 55:1318-1327.
19. Wilkinson I.B., Franklin S.S., Cockcroft J.R. Nitric oxide and the regulation of large artery stiffness: from physiology to pharmacology. Hypertension 2004, 44:112-116.
20. Targonski P.V., Bonetti P.O., Pumper G.M., Higano S.T., Holmes D.R., Lerman A. Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular events. Circulation 2003, 107:2805-2809.
21. Benjamin E.J., Larson M.G., Keyes M.J., et al. Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study. Circulation 2004, 109:613-619.
22. Brook R.D., Bard R.L., Rubenfire M., Ridker P.M., Rajagopalan S. Usefulness of visceral obesity (waist/hip ratio) in predicting vascular endothelial function in healthy overweight adults. Am J Cardiol 2001, 88:1264-1269.
23. Kuvin J.T., Patel A.R., Sidhu M., et al. Relation between high-density lipoprotein cholesterol and peripheral vasomotor function. Am J Cardiol 2003, 92:275-279.
24. Lupattelli G., Lombardini R., Schillaci G., et al. Flow-mediated vasoactivity and circulating adhesion molecules in hypertriglyceridemia: association with small, dense LDL cholesterol particles. Am Heart J 2000, 140:521-526.
25. Esposito K., Ciotola M., Carleo D., et al. Effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome. Diabetes Care 2006, 29:1071-1076.
26. Hamburg N.M., Larson M.G., Vita J.A., et al. Metabolic syndrome, insulin resistance, and brachial artery vasodilator function in Framingham offspring participants without clinical evidence of cardiovascular disease. Am J Cardiol 2008, 101:82-88.
27. Bahia L., Aguiar L.G., Villela N., et al. Relationship between adipokines, inflammation, and vascular reactivity in lean controls and obese subjects with metabolic syndrome. Clinics 2006, 61:433-440.
28. Blanco-Colio L.M., Martín-Ventura J.L., de Teresa E., et al. Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: a substudy of Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration. Am Heart J 2007, 153:881-888.
29. Grassi G., Seravalle G., Brambilla G., et al. Impact of the metabolic syndrome on subcutaneous microcirculation in obese patients. J Hypertens 2010, 28:1708-1714.
30. Schofield I., Malik R., Izzard A., Austin C., Heagerty A. Vascular structural and functional changes in type 2 diabetes mellitus: evidence for the roles of abnormal myogenic responsiveness and dyslipidemia. Circulation 2002, 106:3037-3043.
31. Mathieu-Costello O., Kong A., Ciaraldi T.P., et al. Regulation of skeletal muscle morphology in type 2 diabetic subjects by troglitazone and metformin: relationship to glucose disposal. Metabolism 2003, 52:540-546.
32. Stepp D.W., Pollock D.M., Frisbee J.C. Low-flow vascular remodeling in the metabolic syndrome X. Am J Physiol Heart Circ Physiol 2004, 286:H964-H970.
33. Frisbee J.C. Hypertension-independent microvascular rarefaction in the obese Zucker rat model of the metabolic syndrome. Microcirculation 2005, 12:383-392.
34. Trask A.J., Katz P.S., Kelly A.P., et al. Dynamic micro- and macrovascular remodeling in coronary circulation of obese Ossabaw pigs with metabolic syndrome. J Appl Physiol 2012, 113:1128-1140.
35. Souza-Smith F.M., Katz P.S., Trask A.J., et al. Mesenteric resistance arteries in type 2 diabetic db/db mice undergo outward remodeling. PLoS One 2011, 6:e23337.
36. Benedict K.F., Coffin G.S., Barrett E.J., Skalak T.C. Hemodynamic systems analysis of capillary network remodeling during the progression of type 2 diabetes. Microcirculation 2011, 18:63-73.
37. Sonoyama K., Greenstein A., Price A., Khavandi K., Heagerty T. Vascular remodeling: implications for small artery function and target organ damage. Ther Adv Cardiovasc Dis 2007, 1:129-137.
38. Li J., Flammer A.J., Lennon R.J., et al. Comparison of the effect of the metabolic syndrome and multiple traditional cardiovascular risk factors on vascular function. Mayo Clin Proc 2012, 87:968-975.
39. Lind L. Endothelium-dependent vasodilation, insulin resistance and the metabolic syndrome in an elderly cohort. The Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Atherosclerosis 2008, 196:795-802.
40. Limberg J.K., Harrell J.W., Johansson R.E., et al. Microvascular function in younger adults with obesity and metabolic syndrome: role of oxidative stress. Am J Physiol Heart Circ Physiol 2013, 305:H1230-H1237.
41. Ferri C., Bellini C., Desideri G., et al. Circulating endothelin-1 levels in obese patients with the metabolic syndrome. Exp Clin Endocrinol Diabetes 1997, 105:38-40.
42. Cardillo C., Campia U., Bryant M.B., Panza J.A. Increased activity of endogenous endothelin in patients with type II diabetes mellitus. Circulation 2002, 106:1783-1787.
43. Czernichow S., Greenfield J.R., Galan P., et al. Macrovascular and microvascular dysfunction in the metabolic syndrome. Hypertens Res 2010, 33:293-297.
44. Francischetti E.A., Tibirica E., da Silva E.G., Rodrigues E., Celoria B.M., de Abreu V.G. Skin capillary density and microvascular reactivity in obese subjects with and without metabolic syndrome. Microvasc Res 2011, 81:325-330.
45. Schreihofer A.M., Hair C.D., Stepp D.W. Reduced plasma volume and mesenteric vascular reactivity in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 2005, 288:R253-R261.
46. Levy B.I., Ambrosio G., Pries A.R., Struijker-Boudier H.A. Microcirculation in hypertension: a new target for treatment?. Circulation 2001, 104:735-740.
47. Hanon O., Haulon S., Lenoir H., et al. Relationship between arterial stiffness and cognitive function in elderly subjects with complaints of memory loss. Stroke 2005, 36:2193-2197.
48. Hermans M.M.H., Henry R., Dekker J.M., et al. Estimated glomerular filtration rate and urinary albumin excretion are independently associated with greater arterial stiffness: the Hoorn Study. J Am Soc Nephrol 2007, 18:1942-1952.
49. Goodwill A.G., Frisbee J.C. Oxidant stress and skeletal muscle microvasculopathy in the metabolic syndrome. Vasc Pharmacol 2012, 57:150-159.
50. Ford E.S. The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis 2003, 168:351-358.
51. Emilsson V., Thorleifsson G., Zhang B., et al. Genetics of gene expression and its effect on disease. Nature 2008, 452:423-428.
52. Pietri P., Vyssoulis G., Vlachopoulos C., et al. Relationship between low-grade inflammation and arterial stiffness in patients with essential hypertension. J Hypertens 2006, 24:2231-2238.
53. Recio-Mayoral A., Rimoldi O.E., Camici P.G., Kaski J.C. Inflammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease. J Am Coll Cardiol Img 2013, 6:660-667.
54. Booth A.D., Wallace S., McEniery C.M., et al. Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation. Arthritis Rheum 2004, 50:581-588.
55. Fichtlscherer S., Rosenberger G., Walter D.H., Breuer S., Dimmeler S., Zeiher A.M. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 2000, 102:1000-1006.
56. Hotamisligil G.S., Murray D.L., Choy L.N., Spiegelman B.M. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci U S A 1994, 91:4854-4858.
57. Ritchie S.A., Ewart M.A., Perry C.G., Connell J.M., Salt I.P. The role of insulin and the adipocytokines in regulation of vascular endothelial function. Clin Sci (Lond) 2004, 107:519-532.
58. Bakker E.N., Pistea A., Spaan J.A., et al. Flow-dependent remodeling of small arteries in mice deficient for tissue-type transglutaminase: possible compensation by macrophage-derived factor XIII. Circ Res 2006, 99:86-92.
59. Bouvet C., Moreau S., Blanchette J., de Blois D., Moreau P. Sequential activation of matrix metalloproteinase 9 and transforming growth factor {beta} in arterial elastocalcinosis. Arterioscler Thromb Vasc Biol 2008, 28:856-862.
60. Itani S.I., Ruderman N.B., Schmieder F., Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IκB-α. Diabetes 2002, 51:2005-2011.
61. de Jongh R.T., Serne E.H., Ijzerman R.G., de Vries G., Stehouwer C.D. Free fatty acid levels modulate microvascular function: relevance for obesity-associated insulin resistance, hypertension, and microangiopathy. Diabetes 2004, 53:2873-2882.
62. Demircan N., Gurel A., Armutcu F., Unalacak M., Aktunc E., Atmaca H. The evaluation of serum cystatin C, malondialdehyde, and total antioxidant status in patients with metabolic syndrome. Med Sci Monit 2008, 14:CR97-CR101.
63. Tripathy D., Mohanty P., Dhindsa S., et al. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes 2003, 52:2882-2887.
64. Frisbee J.C. Reduced nitric oxide bioavailability contributes to skeletal muscle microvessel rarefaction in the metabolic syndrome. Am J Physiol Regul Integr Comp Physiol 2005, 289:R307-R316.
65. Chander P.N., Gealekman O., Brodsky S.V., et al. Nephropathy in Zucker diabetic fat rat is associated with oxidative and nitrosative stress: prevention by chronic therapy with a peroxynitrite scavenger ebselen. J Am Soc Nephrol 2004, 15:2391-2403.
66. Eskurza I., Monahan K.D., Robinson J.A., Seals D.R. Effect of acute and chronic ascorbic acid on flow-mediated dilatation with sedentary and physically active human ageing. J Physiol 2004, 556:315-324.
67. Goldin A., Beckman J.A., Schmidt A.M., Creager M.A. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 2006, 114:597-605.
68. Hill B.J., Dixon J.L., Sturek M. Effect of atorvastatin on intracellular calcium uptake in coronary smooth muscle cells from diabetic pigs fed an atherogenic diet. Atherosclerosis 2001, 159:117-124.
69. Reddy G.K. AGE-related cross-linking of collagen is associated with aortic wall matrix stiffness in the pathogenesis of drug-induced diabetes in rats. Microvasc Res 2004, 68:132-142.
70. Brownlee M., Cerami A., Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988, 318:1315-1321.
71. Kohn R.R., Cerami A., Monnier V.M. Collagen aging in vitro by nonenzymatic glycosylation and browning. Diabetes 1984, 33:57-59.
72. Williams B. Angiotensin II, and the pathophysiology of cardiovascular remodeling. Am J Cardiol 2001, 87:10C-17C.
73. Romero M.J., Iddings J.A., Platt D.H., et al. Diabetes-induced vascular dysfunction involves arginase I. Am J Physiol Heart Circ Physiol 2012, 302:H159-H166.
74. Shatanawi A., Romero M.J., Iddings J.A., et al. Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway 2011, C1181-C1192.
75. Stensvold D., Tjønna A.E., Skaug E.-A., et al. Strength training versus aerobic interval training to modify risk factors of metabolic syndrome. J Appl Physiol 2010, 108:804-810.
76. Donley D.A., Fournier S.B., Reger B.L., et al. Aerobic exercise training reduces arterial stiffness in metabolic syndrome. J Appl Physiol 2014, 116:1396-1404.
77. Madden K.M., Lockhart C., Cuff D., Potter T.F., Meneilly G.S. Short-term aerobic exercise reduces arterial stiffness in older adults with type 2 diabetes, hypertension, and hypercholesterolemia. Diabetes Care 2009, 32:1531-1535.
78. Cortez-Cooper M.Y., DeVan A.E., Anton M.M., et al. Effects of high intensity resistance training on arterial stiffness and wave reflection in women. Am J Hypertens 2005, 18:930-934.
79. Miyachi M., Kawano H., Sugawara J., et al. Unfavorable effects of resistance training on central arterial compliance: a randomized intervention study. Circulation 2004, 110:2858-2863.
80. Yoshizawa M., Maeda S., Miyaki A., et al. Effect of 12weeks of moderate-intensity resistance training on arterial stiffness: a randomised controlled trial in women aged 32-59 years. Br J Sports Med 2009, 43:615-618.
81. de Moraes C., Davel A.P., Rossoni L.V., Antunes E., Zanesco A. Exercise training improves relaxation response and SOD-1 expression in aortic and mesenteric rings from high caloric diet-fed rats. BMC Physiol 2008, 8:12.
82. Stapleton P.A., Goodwill A.G., James M.E., Frisbee J.C. Altered mechanisms of endothelium-dependent dilation in skeletal muscle arterioles with genetic hypercholesterolemia. Am J Physiol Regul Integr Comp Physiol 2007, 293:R1110-R1119.
83. Bai Y., Sigala W., Adams G.R., Vaziri N.D. Effect of exercise on cardiac tissue oxidative and inflammatory mediators in chronic kidney disease. Am J Nephrol 2009, 29:213-221.
84. Teixeira de Lemos E., Reis F., Baptista S., et al. Exercise training decreases proinflammatory profile in Zucker diabetic (type 2) fatty rats. Nutrition 2009, 25:330-339.
85. Frisbee J.C., Samora J.B., Peterson J., Bryner R. Exercise training blunts microvascular rarefaction in the metabolic syndrome. Am J Physiol Heart Circ Physiol 2006, 291:H2483-H2492.
86. Fujimoto N., Hastings J.L., Carrick-Ranson G., et al. Cardiovascular effects of one year of alagebrium and endurance exercise training in healthy older individuals. Circ Heart Fail 2013, 6:1155-1164.
87. Aronson D. Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J Hypertens 2003, 21:3-12.